Information:
Fel:
ID
43997
Beskrivning
Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation; ODM derived from: https://clinicaltrials.gov/show/NCT00253214
Länk
https://clinicaltrials.gov/show/NCT00253214
Nyckelord
Versioner (2)
- 2016-04-05 2016-04-05 -
- 2021-09-20 2021-09-20 -
Uppladdad den
20 september 2021
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Alzheimer Disease NCT00253214
Eligibility Alzheimer Disease NCT00253214
- StudyEvent: Eligibility
Similar models
Eligibility Alzheimer Disease NCT00253214
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
alzheimers disease; Outpatients
Item
outpatients with a diagnosis of mild-to-moderate alzheimer's disease according to the national institute of neurological and communicative disorders and the alzheimer's disease and related disorders association (nincds-adrda) criteria (including patients living in residential homes for the elderly or day patients)
boolean
C0002395 (UMLS CUI [1])
C0029921 (UMLS CUI [2])
C0029921 (UMLS CUI [2])
mini mental status examination; alzheimers disease assessment scale
Item
have a mini-mental status examination (mmse) score of 10 - 24, and a score of at least 18 on the cognitive portion of the alzheimer's disease assessment scale (adas-cog-11) with an onset between ages 40 and 90
boolean
C0451306 (UMLS CUI [1])
C0450989 (UMLS CUI [2])
C0450989 (UMLS CUI [2])
medical history cognitive decline
Item
history of at least a 6 months of gradual and progressive cognitive decline
boolean
C0262926 (UMLS CUI [1,1])
C0234985 (UMLS CUI [1,2])
C0234985 (UMLS CUI [1,2])
visit
Item
have a consistent informant to accompany the patient on scheduled visits
boolean
C0545082 (UMLS CUI [1])
parkinsons disease
Item
neurogenerative disorders such as parkinson's disease
boolean
C0030567 (UMLS CUI [1])
cognitive impairment; cerebral trauma; vitamin deficiency; meningitis; aids; metabolic disease ; brain tumor
Item
cognitive impairment resulting from acute cerebral trauma, cerebral damage due to a lack of oxygen, vitamin deficiency, infections such as meningitis or aids, significant endocrine or metabolic disease, mental retardation or a brain tumor
boolean
C1839000 (UMLS CUI [1])
C0558400 (UMLS CUI [2])
C1510471 (UMLS CUI [3])
C0025289 (UMLS CUI [4])
C0001175 (UMLS CUI [5])
C0025517 (UMLS CUI [6])
C0006118 (UMLS CUI [7])
C0558400 (UMLS CUI [2])
C1510471 (UMLS CUI [3])
C0025289 (UMLS CUI [4])
C0001175 (UMLS CUI [5])
C0025517 (UMLS CUI [6])
C0006118 (UMLS CUI [7])
dementia; cerebrovascular disease
Item
dementia caused by small strokes or cerebrovascular disease
boolean
C0497327 (UMLS CUI [1])
C0007820 (UMLS CUI [2])
C0007820 (UMLS CUI [2])
epilepsy; psychiatric disease; peptic ulcer; liver disease; kidney disease; Lung diseases; heart disease
Item
having epilepsy, significant psychiatric disease, active peptic ulcer, clinically significant liver, kidney or lung disorders, or heart disease
boolean
C0014544 (UMLS CUI [1])
C0004936 (UMLS CUI [2])
C0030920 (UMLS CUI [3])
C0023895 (UMLS CUI [4])
C0022658 (UMLS CUI [5])
C0024115 (UMLS CUI [6])
C0018799 (UMLS CUI [7])
C0004936 (UMLS CUI [2])
C0030920 (UMLS CUI [3])
C0023895 (UMLS CUI [4])
C0022658 (UMLS CUI [5])
C0024115 (UMLS CUI [6])
C0018799 (UMLS CUI [7])
contraception status female
Item
females of child bearing potential without adequate contraception
boolean
C0420837 (UMLS CUI [1,1])
C0086287 (UMLS CUI [1,2])
C0086287 (UMLS CUI [1,2])